Though Reckitt Benckiser Plc (RB) has a long history of leadership in the home care industry, the company restructured in early 2018 by placing health as an equal part of the company’s focus (as a part of the newly constructed division, RB Health). The company has a stated focus around improving sales within its chosen powermarkets and is expected to push a strategy of global engagement around its most prominent and broadest-based brands led by the ever-present analgesic Nurofen.
You have no recently viewed reports.
Why not browse through our Featured or Trending Reports to see what we have to offer?
Euromonitor International's report on Reckitt Benckiser Plc. (RB) delivers a detailed strategic analysis of the company's business, examining its performance in the Vitamins and Dietary Supplements market and the global economy.
Company and market share data provide a detailed look at the financial position of Reckitt Benckiser Plc. (RB), while in-depth qualitative analysis will help you understand the brand strategy and growth prospects of Reckitt Benckiser Plc. (RB).
Euromonitor International's company profile reports are written by our Vitamins and Dietary Supplements research team, a dedicated group of analysts that knows the industry inside and out.
Buy this report to inform your planning, strategy, marketing, sales and competitor intelligence functions.
Reports are delivered in PDF format and can be downloaded from your online account immediately after purchase.